↓ Skip to main content

Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer

Overview of attention for article published in BMC Cancer, November 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer
Published in
BMC Cancer, November 2014
DOI 10.1186/1471-2407-14-858
Pubmed ID
Authors

Christian Ostheimer, Matthias Bache, Antje Güttler, Thomas Reese, Dirk Vordermark

Abstract

Circulating baseline levels of the plasma-protein osteopontin (OPN) have been suggested as a prognostic indicator in chemotherapy and surgery for lung cancer. However, the role of this hypoxia-related protein in radiotherapy of lung cancer is unclear. We previously demonstrated the prognostic effect of baseline OPN plasma levels which was increased by co-detection with other hypoxia-related proteins in the radical radiotherapy of non-small-cell lung cancer (NSCLC). This prospective clinical study investigated whether serial OPN measurements during and after curative-intent radiotherapy for NSCLC provide additional or superior prognostic information.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 31%
Student > Doctoral Student 2 13%
Researcher 2 13%
Student > Master 1 6%
Other 1 6%
Other 0 0%
Unknown 5 31%
Readers by discipline Count As %
Agricultural and Biological Sciences 2 13%
Medicine and Dentistry 2 13%
Biochemistry, Genetics and Molecular Biology 1 6%
Physics and Astronomy 1 6%
Nursing and Health Professions 1 6%
Other 2 13%
Unknown 7 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2014.
All research outputs
#15,310,749
of 22,771,140 outputs
Outputs from BMC Cancer
#4,104
of 8,281 outputs
Outputs of similar age
#213,876
of 361,837 outputs
Outputs of similar age from BMC Cancer
#92
of 173 outputs
Altmetric has tracked 22,771,140 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,281 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,837 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 173 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.